Catalyst Funds Management Pty LTD Moderna, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 35,200 shares of MRNA stock, worth $904,640. This represents 0.36% of its overall portfolio holdings.
Number of Shares
35,200Holding current value
$904,640% of portfolio
0.36%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
895Shares Held
242MCall Options Held
21.5MPut Options Held
27M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.04 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$657 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$641 Million0.64% of portfolio
-
State Street Corp Boston, MA17.6MShares$452 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$192 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...